Gazyva® Shows Positive Results in Phase 3 Lupus Nephritis Trial
The Lupus Research Alliance (LRA) and clinical research affiliate Lupus Therapeutics (LT) are excited to share positive news of...
Search Results
You searched for: lupus nephritis
Results found: 1169
Lupus Therapeutics Announces Collaboration to Support the Evaluation of Non-Genetically Modified Cell-Based Therapy for Lupus Nephritis with Artiva Biotherapeutics
Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance, announced a collaboration with Artiva Biotherapeutics, Inc. on...
Analysis Found Rituximab Biosimilar Showed Effectiveness in Treating Pediatric Lupus Nephritis
Rituximab biosimilar BCD020 showed effectiveness in treating lupus nephritis in a pediatric population according to results of a retrospective...
People with Lupus and Especially Lupus Nephritis at Higher Risk for Heart Disease, Study Shows
March 17, 2021
People with systemic lupus erythematosus (SLE) are at risk for cardiovascular diseases, and those with lupus nephritis...
FDA Expedites Existing Drug Gazyva for Lupus Nephritis
September 18, 2019
The LRA is pleased to share that the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy...
Less Risk and Greater Efficacy in Pediatric Lupus Nephritis Treatment
November 3, 2020
There is no doubt about it. The research into the mechanisms of pediatric lupus nephritis conducted by...
Lupus Therapeutics Partners to Evaluate Potential Treatment for SLE and Lupus Nephritis Through North American Trial Network
NEW YORK, NY, June 2, 2023 — Lupus Research Alliance clinical research affiliate Lupus Therapeutics will collaborate with Novartis...
LRA Shares Excitement For What’s Ahead in Lupus Nephritis
January 16, 2020
Up to half of people with lupus will have lupus nephritis – damage to the kidneys that...
Lupkynis® (voclosporin) Granted Marketing Authorization in the European Union for Lupus Nephritis
September 21, 2022
Lupkynis® (voclosporin) was just granted marketing authorization in the European Union as a new treatment for adults...
Study Finds Mycophenolate Mofetil Comparable to Standard Treatment for Pediatric Lupus Nephritis
March 19, 2019
A new study published in Lupus showed that mycophenolate mofetil (MMF) is comparable in effectiveness to the...
LRA Congratulates GSK on FDA Approval of Benlysta® (belimumab) for Children with Lupus Nephritis
NEW YORK, NY. July 27, 2022. The Lupus Research Alliance (LRA) is pleased to share that the U.S. Food...
LRA-funded Research Backs New Lupus Nephritis Clinical Trial
February 28, 2019
The biotechnology company Equillium Inc. just announced plans for a Phase 1 study to test the investigational...